155 related articles for article (PubMed ID: 4877714)
1. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714
[No Abstract] [Full Text] [Related]
2. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
3. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Levy L; Peters JH
Antimicrob Agents Chemother; 1976 Jan; 9(1):102-12. PubMed ID: 769667
[TBL] [Abstract][Full Text] [Related]
4. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
[TBL] [Abstract][Full Text] [Related]
5. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
6. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
Baquillon G; Ferracci C; Diallo J; Saint-AndreƩ P; Pattyn SR
Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
[No Abstract] [Full Text] [Related]
7. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
[No Abstract] [Full Text] [Related]
8. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
9. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
Shepard CC; Tolentino JG; McRae DH
Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
[No Abstract] [Full Text] [Related]
10. Bactericidal action of dapsone against Mycobacterium leprae in mice.
Levy L
Antimicrob Agents Chemother; 1976 Apr; 9(4):614-7. PubMed ID: 773300
[TBL] [Abstract][Full Text] [Related]
11. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
[No Abstract] [Full Text] [Related]
12. The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS.
Peters JH; Shepard CC; Gordon GR; Rojas AV; Elizondo DS
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):143-51. PubMed ID: 776849
[No Abstract] [Full Text] [Related]
13. Rapid bactericidal effect of rifampin on Mycobacterium leprae.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1972 Jul; 21(4):446-9. PubMed ID: 4559066
[No Abstract] [Full Text] [Related]
14. DDS resistance in Ethiopia - a progress report.
Pearson JM; Ross WF; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):140-2. PubMed ID: 776848
[No Abstract] [Full Text] [Related]
15. Dormancy, drug resistance or dependency; some thoughts to ponder.
Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
[No Abstract] [Full Text] [Related]
16. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
17. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
Floch HA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
[TBL] [Abstract][Full Text] [Related]
18. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
[TBL] [Abstract][Full Text] [Related]
19. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of secondary dapsone resistance in Nepal.
Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]